Vol 2019, No 2 (2019)

Table of Contents

Research & Development

Neurocrine Adds Four Gene Therapies to Pipeline with Voyager Collaboration Abstract pdf html
Michelle Liu
GSK Hopes to Lead New Class of Immunotherapies with Merck KGaA Collaboration Abstract pdf html
Michelle Liu
Janssen to Focus on Retinal Diseases with Multi-part MeiraGTx Deal Abstract pdf html
Michelle Liu
Xencor Collaborates with Genentech for Novel Interleukin-15 Bispecific Antibodies Abstract pdf html
Jasmine Kalsi & Michelle Liu
Alexion Pharmaceuticals Takes on Amyloidosis with Caelum Biosciences Abstract pdf html
Michelle Liu

Licensing

AbbVie Joins BCMA Race with Tenebio in a US$90 M Upfront Deal Abstract pdf html
Michelle Liu


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.